Home › Funds › DCF Advisers, LLC › EVO
DCF Advisers, LLC position in EVO
EVOTEC AG · Health Care
DCF Advisers, LLC reported holding 1,048,362 shares of EVO (EVOTEC AG) in its Q3 2026 13F filing — a position valued at US$1.8M, representing 0.53% of its reported portfolio and ranking #45 among its reported holdings. DCF Advisers, LLC has disclosed EVO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How DCF Advisers, LLC's EVO position evolved
DCF Advisers, LLC first disclosed a stake in EVO in Q3 2023 at 49,047 shares (US$484K). The position peaked in Q2 2025 at 1,114,493 shares, worth US$4.7M. Across 13 filings, DCF Advisers, LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,048,362 shares valued at US$1.8M — a reduction of -30,662 shares quarter over quarter.. Notable position changes include a 141% increase in Q2 2024 (shares fell 24% over the following quarter), a 89% increase in Q3 2024 (shares rose 14% over the following quarter), a 227% increase in Q1 2025 (shares rose 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 49.05K | $484.09K | New |
| Q4 2023 | 47.80K | $560.66K | Reduce |
| Q1 2024 | 47.80K | $374.25K | Hold |
| Q2 2024 | 114.95K | $551.77K | Add |
| Q3 2024 | 217.06K | $792.25K | Add |
| Q4 2024 | 229.87K | $956.26K | Add |
| Q1 2025 | 751.58K | $2.51M | Add |
| Q2 2025 | 1.11M | $4.68M | Add |
| Q3 2025 | 1.20M | $4.35M | Add |
| Q4 2025 | 1.20M | $3.69M | Hold |
| Q1 2026 | 1.07M | $2.66M | Reduce |
| Q2 2026 | 1.08M | $3.02M | Add |
| Q3 2026 | 1.05M | $1.79M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EVO and 13F data
EVO (EVOTEC AG) is a Health Care company. 22 other funds we track also report a position in EVO — the largest reported positions include Fore Capital, LLC (US$88K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on DCF Advisers, LLC
FAQ
How long has DCF Advisers, LLC held EVO?
DCF Advisers, LLC has disclosed EVO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is DCF Advisers, LLC's current position in EVO?
As of Q3 2026, DCF Advisers, LLC holds 1.05M shares of EVO (EVOTEC AG), valued at $1.79M, representing 0.53% of its reported portfolio and ranking #45.
Has DCF Advisers, LLC been buying or selling EVO?
In the latest 13F filing (Q3 2026), DCF Advisers, LLC reduced its position in EVO. The position peaked in Q2 2025 at 1.11M shares.
Which other funds hold EVO?
Other major institutional holders of EVO include Fore Capital, LLC, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.